Back to search

Canada· CA-DIN-02244931

MESNA FOR INJECTION

A mesna product containing mesna, registered in Canada by FRESENIUS KABI CANADA LTD. The same ATC class is registered in 12 of our 19 countries.

ATC V03AF01

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedMESNA FOR INJECTIONATCV03AF01REGISTER NO.CA-DIN-02244931PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Mesna is registered in 12 of 19 countries.

Countries holding a registration under ATC V03AF01 (mesna), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 8 of them publish a price we can compare per daily dose

Mesna · ATC V03AF01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
MESNA
Manufacturer
FRESENIUS KABI CANADA LTD
Country
Canada (CA)
ATC code
V03AF01
ATC class
Mesna
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Mesna in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mesna products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Uromitexan
  • Belgium · Uromitexan
  • Bulgaria · Уромитексан
  • Czechia · Uromitexan
  • Germany · Mesna Cell, Mesna-Cell Stadapharm
  • Denmark · Uromitexan, Uromitexan Cum Conservans
  • Estonia · Uromitexan
  • Spain · Mesna Altan, Mucofluid
  • Finland · Uromitexan, Uromitexan Cum Conservans
  • France · Mesna Eg, Uromitexan
  • United Kingdom (Northern Ireland) · Mesna Baxter Healthcare
  • Greece · Uromitexan
  • Croatia · Uromitexan
  • Hungary · Uromitexan
  • Ireland · Uromitexan
  • Iceland · Uromitexan
  • Italy · Uromitexan
  • Lithuania · Uromitexan
  • Luxembourg · Uromitexan
  • Latvia · Uromitexan
  • Malta · Uromitexan
  • Netherlands · Uromitexan
  • Norway · Uromitexan
  • Poland · Uromitexan
  • Portugal · Uromitexan
  • Romania · Uromitexan
  • Sweden · Uromitexan, Uromitexan (Med Konserveringsmedel)
  • Slovakia · Uromitexan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b6896c4d-29f6-4e2c-bccf-d00979c0b07f
GET /v1/drugs/b6896c4d-29f6-4e2c-bccf-d00979c0b07f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02244931",
  "form": "SOLUTION",
  "class": "Human",
  "routes": [
    "INTRAVENOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "V03AF01",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "68929",
  "strengths": [
    "100 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "MESNA"
  ],
  "product_categorization": null
}

See everything about mesna.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.